The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC)

被引:32
作者
Krüger, S
Bier, A
Engel, C
Mangold, E
Pagenstecher, C
Doeberitz, MV
Holinski-Feder, E
Moeslein, G
Schulmann, K
Plaschke, J
Rüschoff, J
Schackert, HK
机构
[1] Dresden Univ Technol, Dept Surg Res, D-01307 Dresden, Germany
[2] Dresden Univ Technol, Inst Clin Genet, D-01307 Dresden, Germany
[3] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04103 Leipzig, Germany
[4] Univ Hosp Bonn, Inst Human Genet, D-53111 Bonn, Germany
[5] Univ Heidelberg, Inst Mol Pathol, D-69120 Heidelberg, Germany
[6] Univ Munich, Dept Med Genet, D-80336 Munich, Germany
[7] Univ Dusseldorf, Dept Surg, D-40225 Dusseldorf, Germany
[8] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Med, D-44892 Bochum, Germany
[9] Klinikum Kassel, Inst Pathol, D-34125 Kassel, Germany
关键词
D O I
10.1136/jmg.2004.028506
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The polymorphic variants at codon 72 of the p53 gene were shown to be functionally distinct in vitro, whereby the arginine (arg) variant induces apoptosis more efficiently than the proline ( pro) variant. From the evidence that the DNA mismatch repair system and p53 interact to maintain genomic integrity, we hypothesized that the codon 72 variation may influence the age of onset of disease in HNPCC patients. We tested 538 patients for p53 codon 72 variants, including 167 unrelated patients with pathogenic germline mutations in MSH2 or MLH1 and colorectal carcinoma as first tumour, 126 patients with sporadic microsatellite stable colorectal cancers, and 245 healthy controls. The median age of onset was 41, 36, and 32 years for MSH2 or MLH1 mutation carriers with arg/arg, arg/pro, and pro/pro genotypes, respectively. The log rank test revealed significant differences in the age of onset between arg/arg and pro/pro individuals ( p = 0.0002) and in arg/ pro versus arg/ arg and pro/pro individuals ( p = 0.0026 and p = 0.0217, respectively). A Cox regression model indicated an additive mode of inheritance. No significant differences in age of onset were observed among different genotype carriers with microsatellite stable tumours. Our results suggest that p53 codon 72 genotypes are associated with the age of onset of colorectal carcinoma in a mismatch repair deficient background in a dose dependent manner. These findings may be relevant for preventive strategies in HNPCC.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 41 条
[31]   Alternative genetic pathways in colorectal carcinogenesis [J].
Olschwang, S ;
Hamelin, R ;
LaurentPuig, P ;
Thuille, B ;
DeRycke, Y ;
Li, YJ ;
Muzeau, F ;
Girodet, J ;
Salmon, RJ ;
Thomas, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :12122-12127
[32]   A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines [J].
RodriguezBigas, MA ;
Boland, CR ;
Hamilton, SR ;
Henson, DE ;
Jass, JR ;
Khan, PM ;
Lynch, H ;
Perucho, M ;
Smyrk, T ;
Sobin, L ;
Srivastava, S .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (23) :1758-1762
[33]   p53 codon 72 polymorphism and risk of cervical cancer in UK [J].
Rosenthal, AN ;
Ryan, A ;
Al-Jehani, RM ;
Storey, A ;
Harwood, CA ;
Jacobs, IJ .
LANCET, 1998, 352 (9131) :871-872
[34]   P53 GERM-LINE HAPLOTYPES ASSOCIATED WITH INCREASED RISK FOR COLORECTAL-CANCER [J].
SJALANDER, A ;
BIRGANDER, R ;
ATHLIN, L ;
STENLING, R ;
RUTEGARD, J ;
BECKMAN, L ;
BECKMAN, G .
CARCINOGENESIS, 1995, 16 (07) :1461-1464
[35]   Role of a p53 polymorphism in the development of human papillomavirus-associated cancer [J].
Storey, A ;
Thomas, M ;
Kalita, A ;
Harwood, C ;
Gardiol, D ;
Mantovani, F ;
Breuer, J ;
Leigh, IM ;
Matlashewski, G ;
Banks, L .
NATURE, 1998, 393 (6682) :229-234
[36]   Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background [J].
Toft, NJ ;
Curtis, LJ ;
Sansom, OJ ;
Leitch, AL ;
Wyllie, AH ;
Riele, HT ;
Arends, MJ ;
Clarke, AR .
ONCOGENE, 2002, 21 (41) :6299-6306
[37]   Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine [J].
Toft, NJ ;
Winton, DJ ;
Kelly, J ;
Howard, LA ;
Dekker, M ;
Riele, HT ;
Arends, MJ ;
Wyllie, AH ;
Margison, GP ;
Clarke, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3911-3915
[38]   Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis [J].
Vasen, HFA ;
Wijnen, JT ;
Menko, FH ;
Kleibeuker, JH ;
Taal, BG ;
Griffioen, G ;
Nagengast, FM ;
MeijersHeijboer, EH ;
Bertario, L ;
Varesco, L ;
Bisgaard, ML ;
Mohr, J ;
Fodde, R ;
Khan, PM .
GASTROENTEROLOGY, 1996, 110 (04) :1020-1027
[39]   MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers:: A study of hereditary nonpolyposis colorectal cancer families [J].
Vasen, HFA ;
Stormorken, A ;
Menko, FH ;
Nagengast, FM ;
Kleibeuker, JH ;
Griffioen, G ;
Taal, BG ;
Moller, P ;
Wijnen, JT .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) :4074-4080
[40]  
Vikhanskaya F, 1999, CLIN CANCER RES, V5, P937